141 related articles for article (PubMed ID: 1711061)
1. Evaluation of antiarrhythmic drug effects with simultaneous analysis of single ventricular premature contractions, couplets and salvos.
Schmidt G; Ulm K; Barthel P; Riemenschneider A; Linzmaier A; Goedel-Meinen L; Baedeker W; Blömer H
J Am Coll Cardiol; 1991 Jul; 18(1):138-43. PubMed ID: 1711061
[TBL] [Abstract][Full Text] [Related]
2. [Spontaneous variability of ventricular arrhythmias in follow-up of anti-arrhythmia therapy].
Schmidt G; Barthel P; Ulm K; Goedel-Meinen L; Baedeker W
Herz; 1990 Feb; 15(1):11-20. PubMed ID: 1690167
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous variability of simple and complex ventricular premature contractions during long time intervals in patients with severe organic heart disease.
Schmidt G; Ulm K; Barthel P; Goedel-Meinen L; Jahns G; Baedeker W
Circulation; 1988 Aug; 78(2):296-301. PubMed ID: 2456168
[TBL] [Abstract][Full Text] [Related]
4. [Spontaneous variability of complex ventricular extrasystoles over a period of up to 4 years].
Schmidt G; Ulm K; Goedel-Meinen L; Barthel P; Jahns G; Stief B; Klein G; Baedeker W; Blömer H
Z Kardiol; 1988 Feb; 77(2):89-92. PubMed ID: 2452524
[TBL] [Abstract][Full Text] [Related]
5. [Spontaneous variability of ventricular arrhythmias in relation to the kind and extent of underlying heart disease].
Schmidt G; Barthel P; Goedel-Meinen L; Baedeker W; Ulm K
Z Kardiol; 1988 Aug; 77(8):523-6. PubMed ID: 2459860
[TBL] [Abstract][Full Text] [Related]
6. [Effect of barucainide on left ventricular ejection fraction in patients with ventricular cardiac arrhythmias].
Scheininger M; Dziersk J; Kullak W; Kors A; Köhler JA; Theisen K
Z Kardiol; 1991 Oct; 80(10):630-6. PubMed ID: 1722935
[TBL] [Abstract][Full Text] [Related]
7. [Dose-dependent anti-arrhythmia effect of retard metoprolol in coronary disease patients with ventricular arrhythmia].
Hartwig CA; Bethge KP; Wenzlaff P; Lichtlen PR
Z Kardiol; 1988 Nov; 77(11):704-12. PubMed ID: 2463717
[TBL] [Abstract][Full Text] [Related]
8. [Spontaneous variability of ventricular extrasystoles: criteria for validating anti-arrhythmia therapy in relation to the length of the control interval].
Schmidt G; Goedel-Meinen L; Ulm K; Jahns G; Barthel P; Stief P; Schaudig UH; Klein G; Baedeker W; Blömer H
Z Kardiol; 1987 May; 76(5):292-5. PubMed ID: 2441534
[TBL] [Abstract][Full Text] [Related]
9. Assessing antiarrhythmic drug efficacy: multivariate considerations.
Ulm K; Schmidt G; Barthel P; Linzmaier A
Stat Med; 1989 Nov; 8(11):1393-400. PubMed ID: 2609049
[TBL] [Abstract][Full Text] [Related]
10. [Arrhythmia profile and sudden cardiac death in early and late resuscitated patients following myocardial infarct].
Trappe HJ; Klein H; Wenzlaff P; Lichtlen PR
Z Kardiol; 1987 Mar; 76(3):127-36. PubMed ID: 2438855
[TBL] [Abstract][Full Text] [Related]
11. [New aspects of the clinical use of anti-arrhythmia agents with special reference to acute therapy of ventricular tachycardia (lidocaine vs. ajmaline)].
Manz M; Mletzko R; Jung W; Lüderitz B
Herz; 1990 Apr; 15(2):79-89. PubMed ID: 2188894
[TBL] [Abstract][Full Text] [Related]
12. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
J Am Coll Cardiol; 1987 Jan; 9(1):169-74. PubMed ID: 3794093
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous variability in ventricular ectopic activity during chronic antiarrhythmic therapy.
Anderson JL; Anastasiou-Nana MI; Menlove RL; Moreno FL; Nanas JN; Barker AH
Circulation; 1990 Sep; 82(3):830-40. PubMed ID: 1697514
[TBL] [Abstract][Full Text] [Related]
14. Days required for 75% suppression of ventricular premature contractions by antiarrhythmic agents obtained from continuous in-hospital ECG monitoring.
Fujito T; Takayanagi K; Shimizu M; Inoue T; Hayashi T; Sakai Y; Morooka S; Takabatake Y
Jpn Heart J; 1994 Mar; 35(2):125-40. PubMed ID: 7517462
[TBL] [Abstract][Full Text] [Related]
15. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia.
Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
J Am Coll Cardiol; 1985 Sep; 6(3):539-44. PubMed ID: 2411776
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the variability in coupling intervals of ventricular premature contractions.
Komatsu T; Ikeda K; Tomoike H
Jpn Circ J; 1993 Aug; 57(8):781-8. PubMed ID: 7689116
[TBL] [Abstract][Full Text] [Related]
17. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
18. Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia.
Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
J Am Coll Cardiol; 1987 Feb; 9(2):398-404. PubMed ID: 3805529
[TBL] [Abstract][Full Text] [Related]
19. Predicting mortality after myocardial infarction from the response of RR variability to antiarrhythmic drug therapy.
Bigger JT; Rolnitzky LM; Steinman RC; Fleiss JL
J Am Coll Cardiol; 1994 Mar; 23(3):733-40. PubMed ID: 7509355
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
Tanabe T; Takahashi K; Yoshioka K; Goto Y
Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
